Benzyl N-Methylcarbamate

Benzyl N-Methylcarbamate

SCHEMBL4127079

C1CC1.CNC(=O)OCc1ccccc1.F[B-](F)(F)F.F[B-](F)(F)F.F[B-](F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.51
ALDH1A1 P00352 3/20 0.50
TOP2A P11388 2/20 0.50
TOP2B Q02880 2/20 0.50
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MGLL Q99685 1/20 0.48
CTSL P07711 1/20 0.47
CTSB P07858 1/20 0.47
CTSS P25774 1/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl N-Methylcarbamate SCHEMBL4139606 0.98 EPHX1 (0.50) EPHX1ALDH1A1TOP2ATOP2BCA12
Benzyl N-Methylcarbamate SCHEMBL645204 0.88 ALDH1A1 (0.62) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL6510776 0.87 ALDH1A1 (0.60) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL6461910 0.85 ALDH1A1 (0.63) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL6444513 0.83 ALDH1A1 (0.61) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL28652926 0.83 MEN1 (0.56) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL5586442 0.82 ALDH1A1 (0.55) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL5156651 0.82 ALDH1A1 (0.55) ALDH1A1TOP2ATOP2BCA12CA1
Benzyl N-Methylcarbamate SCHEMBL11110653 0.81 CTSS (0.53) ALDH1A1TOP2ATOP2BCA12CA1
SCHEMBL3107991 0.79 LMNA (0.58) ALDH1A1NPC1RAB9ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203750-A1 5-HT2C Receptor Agonists as Anorectic Agents HTR2C, HTR2A, HTR5A EPHX1 892/4885ALDH1A1 1292/4885TOP2A 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.